EGFR mutation types and abundance were associated with the overall survival of advanced lung adenocarcinoma patients receiving first-line tyrosine kinase inhibitors - Liu, Yang; Wang, Hongyan; Yang, Sen; Yang, Yuanyuan; Wu, Yufeng; He, Zhen; Ma, Shuxiang; Mo, Yuqing; Chen, Haiyang; Wang, Qiming; Ge, Hong (Journal of Thoracic Disease, 2022)